documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
718 rows where agency_id = "FDA", document_type = "Notice" and posted_year = 2013 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1979-N-0409-0020 | FDA | Blood & Blood Components Error & Accident Reports - CLOSED FDA-1979-N-0409 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-09T14:38:20Z | 0 | 0 | 090000648055637d | |
| FDA-1979-N-0409-0021 | FDA | Blood & Blood Components Error & Accident Reports - CLOSED FDA-1979-N-0409 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-05-09T14:38:40Z | 0 | 0 | 090000648055637e | ||
| FDA-2013-N-1317-0092 | FDA | FDA-2013-N-1317 | Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for Scientific Data and Information; Extension of Comment Period | Notice | Extension of Comment Period | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-03-09T04:59:59Z | 2015-06-20T01:30:52Z | 2013-31294 | 0 | 0 | 09000064814e42b9 |
| FDA-2013-N-1634-0001 | FDA | FDA-2013-N-1634 | Request for Notification From Industry Organizations Interested in Participating in Selection Process for a Nonvoting Industry Representative on the Food Advisory Committee and Request for Nominations for a Nonvoting Industry Representative on the Food Advisory Committee | Notice | General Notice | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-01-02T14:51:51Z | 2013-31321 | 0 | 0 | 09000064814e428c | |
| FDA-2013-N-0001-0120 | FDA | FDA-2013-N-0001 | Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-31T05:00:00Z | 2013 | 12 | 2013-12-31T05:00:00Z | 2014-01-02T15:01:22Z | 2013-31320 | 0 | 0 | 09000064814e431a | |
| FDA-1980-N-0149-0002 | FDA | Platelet Concentrate & Cryoprecipitated Anthihemophilic - CLOSED FDA-1980-N-0149 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-08T12:59:27Z | 0 | 0 | 09000064805bcf63 | |
| FDA-1979-N-0309-0003 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-12T14:04:10Z | 0 | 0 | 09000064805551a5 | ||
| FDA-1980-N-0149-0003 | FDA | Platelet Concentrate & Cryoprecipitated Anthihemophilic - CLOSED FDA-1980-N-0149 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-08T13:00:01Z | 0 | 0 | 09000064805bcf64 | ||
| FDA-2013-N-1676-0001 | FDA | FDA-2013-N-1676 | International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Tapentadol; Tramadol; Ketamine; gamma-Butyrolactone; 22 Additional Substances; Request for Comments | Notice | Request for Comments | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-01-30T04:59:59Z | 2024-11-07T23:00:25Z | 2013-31212 | 1 | 0 | 09000064814e192b |
| FDA-1979-N-0084-0002 | FDA | Food Labeling; Net Weight Labeling Requirements-CLOSED FDA-1979-N-0084 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-12T18:35:27Z | 0 | 0 | 0900006480553e83 | |
| FDA-2013-N-1155-0002 | FDA | FDA-2013-N-1155 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food Labeling Regulations | Notice | General Notice | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-01-30T04:59:59Z | 2014-01-25T02:04:00Z | 2013-31215 | 0 | 0 | 09000064814e19fd |
| FDA-2013-N-0001-0119 | FDA | FDA-2013-N-0001 | Strategies To Address Hemolytic Complications of Immune Globulin Infusions; Public Workshop | Notice | Public Meetings | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T14:17:54Z | 2013-31213 | 0 | 0 | 09000064814e18f0 | |
| FDA-1979-N-0307-0003 | FDA | Allergenic Extract Labeling - CLOSED FDA-1979-N-0307 | Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Withdrawal of Proposed Rule | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T18:42:25Z | 0 | 0 | 0900006480555185 | ||
| FDA-1979-N-0307-0002 | FDA | Allergenic Extract Labeling - CLOSED FDA-1979-N-0307 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2013-12-30T18:42:24Z | 0 | 0 | 0900006480555184 | |
| FDA-1979-N-0084-0003 | FDA | Food Labeling; Net Weight Labeling Requirements-CLOSED FDA-1979-N-0084 | Food Labeling; Net Weight Labeling Requirements - Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal | Notice | Withdrawal | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2014-05-12T18:35:45Z | 0 | 0 | 0900006480553e84 | ||
| FDA-1979-N-0309-0002 | FDA | Antihemophilic Factor (Human) - CLOSED FDA-1979-N-0309 | Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent | Notice | Notice of Intent | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 1991-10-29T04:59:59Z | 2014-05-12T14:03:52Z | 0 | 0 | 09000064805551a4 | |
| FDA-1977-N-0005-0357 | FDA | New Animal Drugs for use in Animal Feeds FDA-1977-N-0005 | Definitions and General Considerations; Revised Procedures re Medicated Feed Applications - Notice of Extension of Comment Period | Notice | Notice of Extension | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 1981-07-09T03:59:59Z | 2013-12-27T14:11:12Z | 0 | 0 | 09000064805d7b84 | |
| FDA-2013-N-1147-0002 | FDA | FDA-2013-N-1147 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition | Notice | General Notice | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-01-28T04:59:59Z | 2013-12-27T15:48:56Z | 2013-30998 | 0 | 0 | 09000064814de952 |
| FDA-2011-N-0179-0019 | FDA | FDA-2011-N-0179 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 | Notice | General Notice | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-01-28T04:59:59Z | 2014-04-04T17:00:53Z | 2013-30996 | 0 | 0 | 09000064814deaed |
| FDA-2013-N-1558-0001 | FDA | FDA-2013-N-1558 | Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products | Notice | 60 Day Proposed Information Collection | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-02-26T04:59:59Z | 2015-02-14T00:29:34Z | 2013-30880 | 0 | 0 | 09000064814debdd |
| FDA-2013-N-1620-0001 | FDA | FDA-2013-N-1620 | Agency Information Collection Activities; Proposed Collection; Comment Request; Information From United States Firms and Processors That Export to the European Community | Notice | General Notice | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-02-25T04:59:59Z | 2024-11-07T23:00:22Z | 2013-30804 | 1 | 0 | 09000064814dcb64 |
| FDA-2013-N-0001-0118 | FDA | FDA-2013-N-0001 | Allergenic Products Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2013-12-26T14:51:40Z | 2013-30799 | 0 | 0 | 09000064814dc88e | |
| FDA-2013-N-1618-0001 | FDA | FDA-2013-N-1618 | Draft Prescription Drug User Fee Act V Information Technology Plan; Availability for Comment | Notice | General Notice | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-02-25T04:59:59Z | 2024-11-07T23:00:00Z | 2013-30818 | 1 | 0 | 09000064814dc9f4 |
| FDA-2013-D-1566-0001 | FDA | FDA-2013-D-1566 | Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances; Availability | Notice | Notice of Availability | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-03-27T03:59:59Z | 2014-03-27T01:02:38Z | 2013-30800 | 0 | 0 | 09000064814dcb61 |
| FDA-2013-N-1615-0001 | FDA | FDA-2013-N-1615 | Draft Generic Drug User Fee Act Information Technology Plan; Availability for Comment | Notice | General Notice | 2013-12-26T05:00:00Z | 2013 | 12 | 2013-12-26T05:00:00Z | 2014-02-25T04:59:59Z | 2014-02-25T02:03:09Z | 2013-31008 | 0 | 0 | 09000064814dcba6 |
| FDA-2013-N-0001-0117 | FDA | FDA-2013-N-0001 | Science Advisory Board to the National Center for Toxicological Research; Notice of Meeting | Notice | Meeting | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T14:55:25Z | 2013-30578 | 0 | 0 | 09000064814d558a | |
| FDA-2013-N-1496-0001 | FDA | FDA-2013-N-1496 | Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Rapid Response Surveys (Generic Clearance) | Notice | General Notice | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2014-02-25T04:59:59Z | 2013-12-24T15:06:13Z | 2013-30630 | 0 | 0 | 09000064814d55d8 |
| FDA-2013-N-0001-0115 | FDA | FDA-2013-N-0001 | Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T14:49:23Z | 2013-30579 | 0 | 0 | 09000064814d52cb | |
| FDA-2013-N-0001-0116 | FDA | FDA-2013-N-0001 | Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-24T05:00:00Z | 2013 | 12 | 2013-12-24T05:00:00Z | 2013-12-24T14:52:21Z | 2013-30580 | 0 | 0 | 09000064814d531a | |
| FDA-1997-N-0057-0009 | FDA | Human Cellular and Tissue-Based Products FDA-1997-N-0057 | See FDA-1997-N-0057-0008 | Notice | Correction | 2013-12-23T05:00:00Z | 2013 | 12 | 2013-12-23T05:00:00Z | 2013-12-24T02:03:01Z | 0 | 0 | 09000064814d1f30 | ||
| FDA-2013-N-0001-0114 | FDA | FDA-2013-N-0001 | Food and Drug Administration/American Academy of Ophthalmology Workshop on Developing Novel Endpoints for Premium Intraocular Lenses; Public Workshop | Notice | Meeting | 2013-12-19T05:00:00Z | 2013 | 12 | 2013-12-19T18:54:11Z | 2013-30148 | 0 | 0 | 09000064814cb583 | ||
| FDA-2013-N-0796-0002 | FDA | FDA-2013-N-0796 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices and Radiation-Emitting Products | Notice | 30 Day Proposed Information Collection | 2013-12-19T05:00:00Z | 2013 | 12 | 2013-12-19T05:00:00Z | 2016-10-28T12:27:02Z | 2013-30149 | 0 | 0 | 09000064814cb0ec | |
| FDA-2013-D-0636-0024 | FDA | FDA-2013-D-0636 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Unique Device Identification System | Notice | 2013-12-19T05:00:00Z | 2013 | 12 | 2013-12-19T18:18:35Z | 2013-30147 | 0 | 0 | 09000064814cb540 | |||
| FDA-2013-N-1588-0001 | FDA | FDA-2013-N-1588 | Agency Information Collection Activities; Proposed Collection; Comment Request; Tobacco Products, Exemptions From Substantial Equivalence Requirements | Notice | 60 Day Proposed Information Collection | 2013-12-19T05:00:00Z | 2013 | 12 | 2013-12-19T05:00:00Z | 2014-02-19T04:59:59Z | 2022-07-25T17:27:30Z | 2013-30137 | 0 | 0 | 09000064814cb538 |
| FDA-2008-D-0150-0019 | FDA | FDA-2008-D-0150 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims | Notice | Notice of Approval | 2013-12-19T05:00:00Z | 2013 | 12 | 2013-12-19T05:00:00Z | 2013-12-19T17:20:33Z | 2013-30146 | 0 | 0 | 09000064814cb007 | |
| FDA-2013-N-1619-0001 | FDA | FDA-2013-N-1619 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements | Notice | 60 Day Proposed Information Collection | 2013-12-19T05:00:00Z | 2013 | 12 | 2013-12-19T05:00:00Z | 2014-02-19T04:59:59Z | 2024-11-07T23:01:20Z | 2013-30185 | 1 | 0 | 09000064814cb57f |
| FDA-2013-N-1204-0006 | FDA | FDA-2013-N-1204 | Draft Risk Profile on Pathogens and Filth in Spices: Availability; Extension of Comment Period | Notice | Extension of Comment Period | 2013-12-18T05:00:00Z | 2013 | 12 | 2013-12-18T05:00:00Z | 2014-03-04T04:59:59Z | 2014-03-07T02:03:54Z | 2013-30055 | 0 | 0 | 09000064814c936a |
| FDA-2010-N-0308-0045 | FDA | FDA-2010-N-0308 | See FDA-2010-N-0308-0046 | Notice | General Notice | 2013-12-18T05:00:00Z | 2013 | 12 | 2013-12-18T05:00:00Z | 2014-03-04T04:59:59Z | 2014-03-09T03:44:59Z | 2013-30055 | 0 | 0 | 09000064814c8a96 |
| FDA-2010-N-0308-0046 | FDA | FDA-2010-N-0308 | Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program | Notice | General Notice | 2013-12-18T05:00:00Z | 2013 | 12 | 2013-12-18T05:00:00Z | 2014-03-04T04:59:59Z | 2014-03-06T21:48:24Z | 2013-29822 | 0 | 0 | 09000064814c8999 |
| FDA-2013-N-0001-0113 | FDA | FDA-2013-N-0001 | Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-17T05:00:00Z | 2013 | 12 | 2013-12-17T05:00:00Z | 2013-12-17T14:24:41Z | 2013-29917 | 0 | 0 | 09000064814c48d2 | |
| FDA-2013-N-0001-0112 | FDA | FDA-2013-N-0001 | Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-12-17T05:00:00Z | 2013 | 12 | 2013-12-17T05:00:00Z | 2013-12-17T14:21:02Z | 2013-29933 | 0 | 0 | 09000064814c4854 | |
| FDA-2013-N-0001-0111 | FDA | FDA-2013-N-0001 | Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting | Notice | General Notice | 2013-12-17T05:00:00Z | 2013 | 12 | 2013-12-17T05:00:00Z | 2013-12-17T14:17:28Z | 2013-29945 | 0 | 0 | 09000064814c478b | |
| FDA-2013-D-0117-0005 | FDA | FDA-2013-D-0117 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Providing Information About Pediatric Uses of Medical Devices Under Section 515A of the Federal Food, Drug, and Cosmetic Act | Notice | General Notice | 2013-12-16T05:00:00Z | 2013 | 12 | 2013-12-16T05:00:00Z | 2014-01-16T04:59:59Z | 2013-12-16T15:33:09Z | 2013-29796 | 0 | 0 | 09000064814c1d1f |
| FDA-2011-D-0889-0156 | FDA | FDA-2011-D-0889 | Guidance for Industry on New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions With Guidance for Industry #209; Availability | Notice | Notice of Availability | 2013-12-12T05:00:00Z | 2013 | 12 | 2013-12-12T05:00:00Z | 2013-12-12T16:37:47Z | 2013-29697 | 0 | 0 | 09000064814b9f8c | |
| FDA-2013-N-1504-0001 | FDA | FDA-2013-N-1504 | Independent Assessment of the Process for the Review of Device Submissions; High Priority Recommendations | Notice | General Notice | 2013-12-12T05:00:00Z | 2013 | 12 | 2013-12-12T05:00:00Z | 2013-12-12T15:04:28Z | 2013-29612 | 0 | 0 | 09000064814ba585 | |
| FDA-2013-D-0928-0003 | FDA | FDA-2013-D-0928 | Draft Guidance for Industry on Recommendations for Preparation and Submission of Animal Food Additive Petitions; Reopening of the Comment Period | Notice | Notice of Availability | 2013-12-10T05:00:00Z | 2013 | 12 | 2013-12-10T05:00:00Z | 2014-01-10T04:59:59Z | 2014-01-10T02:01:50Z | 2013-29392 | 0 | 0 | 09000064814b5b83 |
| FDA-2013-D-1478-0001 | FDA | FDA-2013-D-1478 | Agency Information Collection Activities; Proposed Collection; Comment Request; Providing Waiver-Related Materials in Accordance With Draft Guidance for Industry on Providing Postmarket Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format | Notice | 60 Day Proposed Information Collection | 2013-12-10T05:00:00Z | 2013 | 12 | 2013-12-10T05:00:00Z | 2014-02-11T04:59:59Z | 2013-12-10T14:19:50Z | 2013-29393 | 0 | 0 | 09000064814b5a80 |
| FDA-2013-N-1434-0001 | FDA | FDA-2013-N-1434 | Draft Guidance for Industry on Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules; Availability | Notice | Notice of Availability | 2013-12-10T05:00:00Z | 2013 | 12 | 2013-12-10T05:00:00Z | 2014-03-11T03:59:59Z | 2014-04-06T02:24:30Z | 2013-29395 | 0 | 0 | 09000064814b5c63 |
| FDA-2013-N-0853-0002 | FDA | FDA-2013-N-0853 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical DevicesCurrent Good Manufacturing Practice Quality System Regulation | Notice | 30 Day Proposed Information Collection | 2013-12-10T05:00:00Z | 2013 | 12 | 2013-12-10T05:00:00Z | 2014-01-10T04:59:59Z | 2013-12-10T15:23:32Z | 2013-29394 | 0 | 0 | 09000064814b5b4b |
| FDA-2013-N-0823-0002 | FDA | FDA-2013-N-0823 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Over-the-Counter Drugs; Labeling Requirements | Notice | 30 Day Proposed Information Collection | 2013-12-05T05:00:00Z | 2013 | 12 | 2013-12-05T05:00:00Z | 2014-01-07T04:59:59Z | 2013-12-08T15:37:58Z | 2013-29079 | 0 | 0 | 09000064814a9e18 |
| FDA-2013-D-1464-0001 | FDA | FDA-2013-D-1464 | Draft Guidance for Industry on Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Availability | Notice | Notice of Availability | 2013-12-05T05:00:00Z | 2013 | 12 | 2013-12-05T05:00:00Z | 2014-03-06T04:59:59Z | 2014-03-06T02:01:21Z | 2013-29081 | 0 | 0 | 09000064814a9ea0 |
| FDA-2007-D-0369-0277 | FDA | FDA-2007-D-0369 | Draft Guidance for Industry; Availability: Bioequivalence Recommendations for Paliperidone Palmitate Extended-Release Injectable Suspension | Notice | Notice of Availability | 2013-12-05T05:00:00Z | 2013 | 12 | 2013-12-05T05:00:00Z | 2014-02-04T04:59:59Z | 2014-02-13T02:02:08Z | 2013-29080 | 0 | 0 | 09000064814a9e1e |
| FDA-2013-D-1444-0001 | FDA | FDA-2013-D-1444 | Draft Guidance; Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Withdrawal of Guidances | Notice | Notice of Availability | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2014-02-04T04:59:59Z | 2014-02-05T02:03:21Z | 2013-28963 | 0 | 0 | 09000064814a6225 |
| FDA-2013-N-0579-0002 | FDA | FDA-2013-N-0579 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing; Forms FDA 3486 and 3486A | Notice | 30 Day Proposed Information Collection | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2014-01-04T04:59:59Z | 2013-12-30T02:01:45Z | 2013-28990 | 0 | 0 | 09000064814a61ed |
| FDA-2013-N-0795-0002 | FDA | FDA-2013-N-0795 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Third-Party Review Under the Food and Drug Administration Modernization Act | Notice | 60 Day Proposed Information Collection | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2014-01-04T04:59:59Z | 2013-12-04T17:27:21Z | 2013-29010 | 0 | 0 | 09000064814a6173 |
| FDA-2013-N-1429-0001 | FDA | FDA-2013-N-1429 | Draft Guidance for Industry on Registration for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Availability | Notice | Notice of Availability | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2014-02-04T04:59:59Z | 2020-04-23T20:10:32Z | 2013-28962 | 0 | 0 | 09000064814a62d0 |
| FDA-2012-D-1083-0007 | FDA | FDA-2012-D-1083 | Guidance for Industry and Food and Drug Administration Staff; Civil Money Penalties for Tobacco Retailers: Responses to Frequently Asked Questions; Availability | Notice | Notice of Availability | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2015-03-24T19:07:23Z | 2013-28961 | 0 | 0 | 09000064814a62d1 | |
| FDA-2013-N-1428-0001 | FDA | FDA-2013-N-1428 | Draft Guidance for Industry on Interim Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Availability | Notice | Notice of Availability | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2014-02-04T04:59:59Z | 2019-07-17T12:21:27Z | 2013-28960 | 0 | 0 | 09000064814a6172 |
| FDA-2013-N-0797-0003 | FDA | FDA-2013-N-0797 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Tissue Intended for Transplantation | Notice | 30 Day Proposed Information Collection | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T05:00:00Z | 2014-01-04T04:59:59Z | 2014-01-05T02:56:10Z | 2013-28989 | 0 | 0 | 09000064814a6316 |
| FDA-2013-N-0719-0002 | FDA | FDA-2013-N-0719 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products | Notice | 30 Day Proposed Information Collection | 2013-12-02T05:00:00Z | 2013 | 12 | 2013-12-02T05:00:00Z | 2014-01-03T04:59:59Z | 2013-12-03T01:11:39Z | 2013-28735 | 0 | 0 | 09000064814a2106 |
| FDA-2013-N-0748-0002 | FDA | FDA-2013-N-0748 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Focus Groups About Drug Products as Used by the Food and Drug Administration | Notice | 30 Day Proposed Information Collection | 2013-12-02T05:00:00Z | 2013 | 12 | 2013-12-02T05:00:00Z | 2014-01-03T04:59:59Z | 2013-12-03T01:04:57Z | 2013-28736 | 0 | 0 | 09000064814a1fbf |
| FDA-2013-N-0716-0002 | FDA | FDA-2013-N-0716 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Designated New Animal Drugs for Minor Use and Minor Species | Notice | General Notice | 2013-11-29T05:00:00Z | 2013 | 11 | 2013-11-29T05:00:00Z | 2013-12-31T04:59:59Z | 2013-11-29T17:13:49Z | 2013-28598 | 0 | 0 | 090000648149f1ca |
| FDA-2013-N-1439-0001 | FDA | FDA-2013-N-1439 | Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Event Program for Medical Products | Notice | General Notice | 2013-11-29T05:00:00Z | 2013 | 11 | 2013-11-29T05:00:00Z | 2014-01-29T04:59:59Z | 2013-11-29T17:16:39Z | 2013-28600 | 0 | 0 | 090000648149f214 |
| FDA-2013-N-1422-0001 | FDA | FDA-2013-N-1422 | Agency Information Collection Activities; Proposed Collection; Comment Request; Eye Tracking Study of Direct-to-Consumer Prescription Drug Advertisement Viewing | Notice | General Notice | 2013-11-29T05:00:00Z | 2013 | 11 | 2013-11-29T05:00:00Z | 2014-01-29T04:59:59Z | 2014-09-04T17:41:07Z | 2013-28599 | 0 | 0 | 090000648149f075 |
| FDA-2012-D-0880-0009 | FDA | FDA-2012-D-0880 | Draft Guidance for Industry on Generic Drug User Fee Amendments of 2012: Questions and Answers (Revision 1); Reopening of the Comment Period | Notice | General Notice | 2013-11-27T05:00:00Z | 2013 | 11 | 2013-11-27T05:00:00Z | 2013-12-12T04:59:59Z | 2016-11-18T14:46:02Z | 2013-28392 | 0 | 0 | 090000648149c2b6 |
| FDA-2013-N-1424-0001 | FDA | FDA-2013-N-1424 | Transport Format for the Submission of Regulatory Study Data; Notice of Pilot Project | Notice | General Notice | 2013-11-27T05:00:00Z | 2013 | 11 | 2013-11-27T05:00:00Z | 2014-01-28T04:59:59Z | 2024-11-12T05:23:15Z | 2013-28391 | 1 | 0 | 090000648149c255 |
| FDA-2013-N-0001-0110 | FDA | FDA-2013-N-0001 | Risk Communications Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-11-27T05:00:00Z | 2013 | 11 | 2013-11-27T05:00:00Z | 2013-11-27T15:57:46Z | 2013-28435 | 0 | 0 | 090000648149c214 | |
| FDA-2013-N-1423-0001 | FDA | FDA-2013-N-1423 | Agency Information Collection Activities; Proposed Collection; Comment Request; Importer's Entry Notice | Notice | General Notice | 2013-11-27T05:00:00Z | 2013 | 11 | 2013-11-27T05:00:00Z | 2014-01-28T04:59:59Z | 2024-11-12T05:23:18Z | 2013-28438 | 1 | 0 | 090000648149c36a |
| FDA-2007-D-0369-0275 | FDA | FDA-2007-D-0369 | Draft Guidance for Industry on Bioequivalence Recommendations for Fluticasone Propionate; Salmeterol Xinafoate; Reopening of the Comment Period | Notice | Notice of Availability | 2013-11-27T05:00:00Z | 2013 | 11 | 2013-11-27T05:00:00Z | 2013-12-12T04:59:59Z | 2013-12-08T18:23:54Z | 2013-28394 | 0 | 0 | 090000648149c332 |
| FDA-2013-N-0002-0040 | FDA | FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid | Notice | General Notice | 2013-11-26T05:00:00Z | 2013 | 11 | 2013-11-26T05:00:00Z | 2013-11-26T14:17:06Z | 2013-28255 | 0 | 0 | 0900006481498795 | |
| FDA-2011-D-0305-0058 | FDA | FDA-2011-D-0305 | Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2013-11-25T05:00:00Z | 2013 | 11 | 2013-11-25T05:00:00Z | 2013-11-26T13:37:08Z | 2013-28084 | 0 | 0 | 0900006481495921 | |
| FDA-2012-D-1038-0017 | FDA | FDA-2012-D-1038 | Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products; Availability | Notice | Notice of Availability | 2013-11-25T05:00:00Z | 2013 | 11 | 2013-11-25T05:00:00Z | 2013-11-26T13:43:05Z | 2013-28173 | 0 | 0 | 0900006481495aaa | |
| FDA-2013-N-0002-0038 | FDA | FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone | Notice | General Notice | 2013-11-22T05:00:00Z | 2013 | 11 | 2013-11-22T05:00:00Z | 2013-11-22T14:37:17Z | 2013-27916 | 0 | 0 | 09000064814910b5 | |
| FDA-2013-D-0269-0003 | FDA | FDA-2013-D-0269 | Guidance for Industry: Purchasing Reef Fish Species Associated with the Hazard of Ciguatera Fish Poisoning; Availability | Notice | Notice of Availability | 2013-11-22T05:00:00Z | 2013 | 11 | 2013-11-22T05:00:00Z | 2013-11-22T15:33:10Z | 2013-27913 | 0 | 0 | 090000648149122c | |
| FDA-2013-P-0573-0003 | FDA | FDA-2013-P-0573 | Determination That BANZEL (Rufinamide) Tablet, 100 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | General Notice | 2013-11-21T05:00:00Z | 2013 | 11 | 2013-11-21T05:00:00Z | 2013-11-21T14:54:32Z | 2013-27874 | 0 | 0 | 090000648148e297 | |
| FDA-2013-N-1432-0001 | FDA | FDA-2013-N-1432 | Agency Information Collection Activities; Proposed Collection; Comment Request; Guide to Minimize Microbial Food Safety Hazards of Fresh-Cut Fruits and Vegetables | Notice | General Notice | 2013-11-20T05:00:00Z | 2013 | 11 | 2013-11-20T05:00:00Z | 2014-01-22T04:59:59Z | 2014-01-22T02:01:42Z | 2013-27782 | 0 | 0 | 090000648148bb1a |
| FDA-2013-N-0001-0108 | FDA | FDA-2013-N-0001 | Changing Regulatory and Reimbursement Paradigms for Medical Devices in the Treatment of Obesity and Metabolic Diseases: How to Estimate and Reward True Patient-Centric Value in Innovation; Public Workshop | Notice | Meeting | 2013-11-20T05:00:00Z | 2013 | 11 | 2013-11-20T05:00:00Z | 2013-11-20T15:29:32Z | 2013-27771 | 0 | 0 | 090000648148bb54 | |
| FDA-1999-D-4079-0004 | FDA | Product Name Placement,Size, & Prominence in Advertising FDA-1999-D-4079 | Draft Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability | Notice | Notice of Availability | 2013-11-20T05:00:00Z | 2013 | 11 | 2013-11-20T05:00:00Z | 2014-01-25T04:59:59Z | 2014-01-17T02:02:42Z | 2013-27770 | 0 | 0 | 090000648148bad1 |
| FDA-2013-D-1358-0001 | FDA | FDA-2013-D-1358 | Draft Guidance for Industry: Recommendations for Premarket Notification (510(k)) Submissions for Nucleic Acid-Based Human Leukocyte Antigen Test Kits Used for Matching of Donors and Recipients in Transfusion and Transplantation; Availability | Notice | Notice of Availability | 2013-11-20T05:00:00Z | 2013 | 11 | 2013-11-20T05:00:00Z | 2014-02-19T04:59:59Z | 2015-07-13T17:54:08Z | 2013-27774 | 0 | 0 | 090000648148bc0a |
| FDA-2013-D-0576-0003 | FDA | FDA-2013-D-0576 | Draft Guidance for Industry: Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products; Extension of Comment Period | Notice | Notice of Availability | 2013-11-20T05:00:00Z | 2013 | 11 | 2013-11-20T05:00:00Z | 2014-05-10T03:59:59Z | 2014-05-13T14:34:04Z | 2013-27769 | 0 | 0 | 090000648148ba3d |
| FDA-2013-N-0879-0002 | FDA | FDA-2013-N-0879 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe and Sanitary Processing and Importing of Fish and Fishery Products | Notice | 30 Day Proposed Information Collection | 2013-11-20T05:00:00Z | 2013 | 11 | 2013-11-20T05:00:00Z | 2013-12-21T04:59:59Z | 2016-12-08T13:41:55Z | 2013-27775 | 0 | 0 | 090000648148ba3c |
| FDA-2013-N-1427-0001 | FDA | FDA-2013-N-1427 | Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice | Notice | 60 Day Proposed Information Collection | 2013-11-20T05:00:00Z | 2013 | 11 | 2013-11-20T05:00:00Z | 2014-01-22T04:59:59Z | 2016-08-09T18:09:39Z | 2013-27811 | 0 | 0 | 090000648148bb55 |
| FDA-2013-N-0878-0002 | FDA | FDA-2013-N-0878 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Notification for a New Dietary Ingredient | Notice | General Notice | 2013-11-18T05:00:00Z | 2013 | 11 | 2013-11-18T05:00:00Z | 2013-12-19T04:59:59Z | 2015-02-11T23:13:29Z | 2013-27536 | 0 | 0 | 0900006481486d8c |
| FDA-2013-N-1119-0002 | FDA | FDA-2013-N-1119 | Agency Information Collection Activities; Proposed Collection; Comment Request; Food Canning Establishment Registration, Process Filing, and Recordkeeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically Sealed Containers; Extension of Comment Period | Notice | Extension of Comment Period | 2013-11-18T05:00:00Z | 2013 | 11 | 2013-11-18T05:00:00Z | 2024-11-12T05:23:33Z | 2013-27537 | 1 | 0 | 0900006481486d8d | |
| FDA-2013-N-1394-0001 | FDA | FDA-2013-N-1394 | Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Special Protocol Assessment | Notice | General Notice | 2013-11-18T05:00:00Z | 2013 | 11 | 2013-11-18T05:00:00Z | 2014-01-18T04:59:59Z | 2014-01-14T19:56:34Z | 2013-27503 | 0 | 0 | 0900006481486bba |
| FDA-2013-D-0715-0001 | FDA | FDA-2013-D-0715 | Draft Guidance for Industry on Acrylamide in Foods; Availability | Notice | Notice of Availability | 2013-11-15T05:00:00Z | 2013 | 11 | 2013-11-15T05:00:00Z | 2014-01-15T04:59:59Z | 2014-01-15T02:03:26Z | 2013-27362 | 0 | 0 | 0900006481481e8f |
| FDA-2013-N-1038-0003 | FDA | FDA-2013-N-1038 | Over-the-Counter Ophthalmic Drug Products--Emergency Use Eyewash Products; Rescheduling of Public Hearing | Notice | Public Meetings | 2013-11-15T05:00:00Z | 2013 | 11 | 2013-11-15T05:00:00Z | 2014-06-07T03:59:59Z | 2014-06-07T01:06:55Z | 2013-27359 | 0 | 0 | 0900006481481db2 |
| FDA-2013-N-1306-0001 | FDA | FDA-2013-N-1306 | International Medical Device Regulators Forum; Medical Device Single Audit Program International Coalition Pilot Program; Availability | Notice | Announcement | 2013-11-15T05:00:00Z | 2013 | 11 | 2013-11-15T05:00:00Z | 2024-11-12T05:24:37Z | 2013-27358 | 1 | 0 | 0900006481481dfb | |
| FDA-1994-D-0007-0003 | FDA | Utility Study Anti-Salmonella Chemical Food Adds in Feeds FDA-1994-D-0007 | Guidance for Industry; Availability: Studies to Evaluate the Utility of Anti-Salmonella Chemical Food Additives in Feeds | Notice | Request for Comments | 2013-11-14T05:00:00Z | 2013 | 11 | 2013-11-14T05:00:00Z | 2014-01-14T04:59:59Z | 2014-01-18T02:04:25Z | 2013-27194 | 0 | 0 | 090000648147d87c |
| FDA-2013-N-1393-0001 | FDA | FDA-2013-N-1393 | Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions | Notice | 60 Day Proposed Information Collection | 2013-11-14T05:00:00Z | 2013 | 11 | 2013-11-14T05:00:00Z | 2014-01-14T04:59:59Z | 2016-10-24T13:43:28Z | 2013-27226 | 0 | 0 | 090000648147d67b |
| FDA-2000-N-0110-0008 | FDA | Proposal to Debar Bruce I Diamond PhD, Opportunity for Heari FDA-2000-N-0110 | Debarment Orders: Bruce I. Diamond; Denial of Hearing | Notice | General Notice | 2013-11-14T05:00:00Z | 2013 | 11 | 2013-11-14T05:00:00Z | 2013-11-14T15:45:07Z | 2013-27186 | 0 | 0 | 090000648147d79f | |
| FDA-2013-D-1279-0001 | FDA | FDA-2013-D-1279 | Medical Device Development Tools; Draft Guidance for Industry, Tool Developers, and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2013-11-14T05:00:00Z | 2013 | 11 | 2013-11-14T05:00:00Z | 2013-11-14T16:39:29Z | 2013-27233 | 0 | 0 | 090000648147d82e | |
| FDA-2013-D-0880-0006 | FDA | FDA-2013-D-0880 | Draft Guidance for Industry on Frequently Asked Questions About Medical Foods; Second Edition; Reopening of the Comment Period | Notice | General Notice | 2013-11-14T05:00:00Z | 2013 | 11 | 2013-11-14T05:00:00Z | 2013-12-17T04:59:59Z | 2016-03-18T18:15:07Z | 2013-27213 | 0 | 0 | 090000648147d709 |
| FDA-2013-N-1152-0001 | FDA | FDA-2013-N-1152 | Agency Information Collection Activities; Proposed Collection; Comment Request; Petition to Request an Exemption From 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements | Notice | General Notice | 2013-11-14T05:00:00Z | 2013 | 11 | 2013-11-14T05:00:00Z | 2014-01-14T04:59:59Z | 2014-01-14T16:41:07Z | 2013-27222 | 0 | 0 | 090000648147d67d |
| FDA-2013-N-0001-0106 | FDA | FDA-2013-N-0001 | Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-11-12T05:00:00Z | 2013 | 11 | 2013-11-12T05:00:00Z | 2013-11-12T19:54:30Z | 2013-26891 | 0 | 0 | 090000648147745b | |
| FDA-2013-N-0001-0105 | FDA | FDA-2013-N-0001 | Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting | Notice | Meeting | 2013-11-12T05:00:00Z | 2013 | 11 | 2013-11-12T05:00:00Z | 2013-11-12T19:51:02Z | 2013-26868 | 0 | 0 | 0900006481477329 | |
| FDA-2013-N-1361-0001 | FDA | FDA-2013-N-1361 | Determination That ADDERALL (Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate) Tablet and 13 Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | General Notice | 2013-11-12T05:00:00Z | 2013 | 11 | 2013-11-12T05:00:00Z | 2013-11-12T19:58:09Z | 2013-26856 | 0 | 0 | 09000064814774f2 | |
| FDA-2013-N-0764-0005 | FDA | FDA-2013-N-0764 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Animal Feed Regulatory Program Standards | Notice | 30 Day Proposed Information Collection | 2013-11-08T05:00:00Z | 2013 | 11 | 2013-11-08T05:00:00Z | 2013-12-10T04:59:59Z | 2016-04-04T11:10:30Z | 2013-26778 | 0 | 0 | 090000648147379d |
| FDA-2013-N-0001-0107 | FDA | FDA-2013-N-0001 | Sixth Annual Sentinel Initiative; Public Workshop | Notice | Meeting | 2013-11-08T05:00:00Z | 2013 | 11 | 2013-11-08T05:00:00Z | 2013-11-12T20:11:03Z | 2013-26855 | 0 | 0 | 09000064814737a3 | |
| FDA-2013-N-1317-0001 | FDA | FDA-2013-N-1317 | Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for Scientific Data and Information | Notice | Request for Comments | 2013-11-08T05:00:00Z | 2013 | 11 | 2013-11-08T05:00:00Z | 2014-01-08T04:59:59Z | 2014-12-14T02:23:47Z | 2013-26854 | 0 | 0 | 090000648147367f |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);